Franklin Covey (FC) Financials

Franklin Covey’s recent results show an improving earnings trend, but weaker liquidity and cash generation remain important risks. In Q3 fiscal 2026, revenue increased 1.0% year over year to $67.8 million, while operating income improved to $4.2 million from a $2.2 million loss. Net income attributable to common shareholders was $3.1 million, or $0.27 per diluted share, compared with a $1.3 million loss, or negative $0.11 per share, in Q3 fiscal 2025.

The earnings improvement was driven partly by lower restructuring charges, which fell to $696,000 from $4.7 million in the prior-year quarter. However, gross margin declined to approximately 73.9% from 76.5%, and revenue remains below the $84.1 million recorded in Q4 fiscal 2024. Fiscal 2026 revenue was also down year over year in Q1 and essentially flat in Q2 before recovering modestly in Q3.

Cash generation is more concerning. Operating cash flow was only $1.1 million in Q3 fiscal 2026, down from $6.3 million in the comparable quarter, as changes in operating assets and liabilities consumed $7.0 million. Cash and equivalents fell to $12.0 million at May 31, 2026, compared with $33.7 million a year earlier and $52.1 million in Q3 fiscal 2022.

Franklin Covey has reduced its debt substantially, with no short-term or long-term debt reported at the end of Q3 fiscal 2026. Nevertheless, total current liabilities of $140.1 million exceeded current assets of $91.8 million, producing a current ratio below 1.0. The company’s large deferred revenue balance can provide future revenue visibility, but it also means the balance sheet carries significant near-term obligations.

• Profitability rebounded: Q3 fiscal 2026 operating income rose to $4.2 million from a $2.2 million operating loss, and net income attributable to common shareholders improved to $3.1 million from a $1.3 million loss.
• Restructuring costs moderated: The Q3 restructuring charge declined to $696,000 from $4.7 million in the prior-year quarter, providing a meaningful lift to reported earnings.
• Debt has been eliminated: Franklin Covey reported zero short-term and long-term debt at the end of Q3 fiscal 2026, compared with $835,000 of short-term debt in Q2 and more than $2 million of total debt in several earlier periods.
• Revenue showed modest sequential recovery: Q3 fiscal 2026 revenue of $67.8 million increased from $59.6 million in Q2, although it remained below the prior-year peak levels.
• Deferred revenue remains substantial: Current deferred revenue was $93.0 million at Q3 fiscal 2026, which may support future revenue recognition but also represents a significant short-term liability.
• Share repurchases have been significant: The company has regularly repurchased shares, including $10.7 million in Q1 fiscal 2026 and $8.3 million in Q3 fiscal 2025. This can support earnings per share over time, but it has also contributed to the large negative treasury-stock balance.
• Cash reserves have deteriorated: Cash declined to $12.0 million at May 31, 2026, down approximately 64% from $33.7 million a year earlier and roughly 77% from $52.1 million in Q3 fiscal 2022.
• Operating cash flow weakened sharply: Q3 fiscal 2026 operating cash flow fell to $1.1 million from $6.3 million year over year. Q1 fiscal 2026 operating cash flow was also only $98,000, indicating inconsistent cash conversion.
• Liquidity is tight: Current assets of $91.8 million were well below current liabilities of $140.1 million, resulting in a current ratio of approximately 0.66.
• Margins and asset levels remain under pressure: Q3 gross margin fell to about 73.9% from 76.5% a year earlier, while total assets declined to $198.0 million from $218.3 million in Q3 fiscal 2025 and shareholders’ equity fell to $42.9 million from $65.6 million.